Inato · 1 month ago
Sales Director - Site Partnerships
Inato is a Tech for Good company striving to bring clinical research to every patient, regardless of their background. The Sales Director will be responsible for closing partnerships with research sites to integrate their EHR systems and deploy Inato’s AI pre-screening tool, running the entire sales process from prospecting to closing.
Artificial Intelligence (AI)Clinical TrialsHealth CareMachine LearningPharmaceutical
Responsibilities
Own full cycle sales to research sites: targeted outbound, discovery, product walkthroughs, value articulation, negotiation, and close
Use your existing site contacts to close partnerships and cultivate new relationships to drive additional growth
Partner with Customer Success for an efficient handoff into onboarding and EHR integration
Maintain pipeline hygiene and forecasting in our CRM; drive predictable weekly activity and progression
Capture the voice of the site to inform pricing, packaging, and product
Represent Inato at industry events and within the site community
Qualification
Required
3+ years in full cycle sales to clinical research sites (or closely related provider workflows), selling workflow integrated software or data solutions
Demonstrated hunter discipline: consistent outbound activity, multi-threading, and pipeline progression
Strong site workflow fluency (EHR, pre-screening/patient ID, enrollment operations) and consultative selling skills
Existing network and relationships across research sites
Excellent communication skills and ability to clearly explain value to customers
CRM excellence and data driven pipeline management
Must be U.S.-based - East Coast highly preferred
Preferred
Familiarity with EHR integrations and data privacy/security considerations in healthcare
Early or mid-stage startup experience
Benefits
6 weeks vacation
9 holidays + 4 floating holidays
16 weeks of paid maternity leave
Comprehensive health insurance
Competitive salary & equity
Company
Inato
Inato is a platform designed for clinical trials that can unlock research site potential.
Funding
Current Stage
Growth StageTotal Funding
$35.53MKey Investors
Cathay InnovationSerena
2023-03-29Series A· $20M
2020-02-04Series A· $14M
2017-11-15Seed· $1.53M
Recent News
PR Newswire
2025-09-15
Company data provided by crunchbase